Products

Proteomics International's product development pipeline and commercialised Promarker^® products are based on the proteins found in individuals with a targeted clinical condition. The Company has developed a versatile platform technology for discovering proteins which strongly correlate (positively and/or negatively) with a clinical condition. By comparing blood or other biological samples taken from individuals with and without the condition, our team is able to produce a set of highly specific “biomarkers”. These biomarkers are biological signatures for that condition. When these data are combined with clinical factors in our proprietary clinical algorithm "Promarker Hub", our biomarker-based diagnostics enable clinicians with a window onto individual's unique biochemical activity.